,i #aacth ,,congress #b;d ,session ,h4 ,r4 #ddge ,,in ,,the ,,house ,,of ,,representatives ,april #aj1 #bjad ,mr4 ,griffith of ,virginia 7for himself and ,mr4 ,hanna7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to allow the manufacture1 importation1 distribution1 and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,compassionate ,freedom of ,choice ,act of #bjad4 #b4 ,drugs and devices for use by terminally ill patients ,the ,federal ,food1 ,drug1 and ,cosmetic ,act is amended by inserting after section #efa 7#ba ,u4,s4,c4 #cfj;bbb7 the following3 #efa;,a4 ,drugs and devices for use by terminally ill patients 7a7 ,in general ,nothing in this ,act or section #cea of the ,public ,health ,service ,act prevents or restricts1 and the ,food and ,drug ,administration shall not implement or enforce any provision of law preventing or restricting1 the manufacture1 importation1 distribution1 or sale of an investigational drug or device intended for use by a terminally ill patient in accordance with subsection 7b74 7b7 ,patient requirements ,in order for an investigational drug or device to be intended for use in accordance with this subsection1 such drug or device must be intended for use by a patient who has-- 7#a7 been diagnosed with a terminal illness by a licensed physician2 7#b7 been informed by a licensed physician that no drug or device that is lawfully marketed in the ,united ,states is likely to cure the illness2 and 7#c7 executed a written informed consent document that states-- 7,a7 the known and potential risks and benefits of such drug or device2 and 7,b7 any indications of the illness for which a drug or device is lawfully marketed1 or for which treatment is otherwise available1 in the ,united ,states4 7c7 ,prohibition on requiring the disclosure1 collection1 and reporting of certain information by ,food and ,drug ,administration 7#a7 ,in general ,the ,commissioner of ,food and ,drugs may not require the disclosure1 collection1 or reporting of-- 7,a7 any information related to the delivery1 administration1 or use of an investigational drug or device pursuant to this section2 or 7,b7 any information related to the clinical outcomes experienced by a terminally ill patient supplied an investigational drug or device pursuant to this section4 7#b7 ,exception ,nothing in this subsection prevents the sponsor of a clinical trial from voluntarily disclosing1 collecting1 or reporting information to the ,food and ,drug ,administration4 7d7 ,definition of investigational drug or device ,in this section1 the term investigational drug or device means a drug or device that-- 7#a7 has not yet been approved1 licensed1 or cleared for commercial distribution under section #eje1 #eaj7k71 or #eae of this ,act or section #cea of the ,public ,health ,service ,act1 and cannot otherwise be lawfully marketed in the ,united ,states2 and 7#b7 is or has been the subject of one or more clinical trials4 4 #c4 ,liability protection ,the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cja et seq47 is amended by inserting after section #efa;,a1 as inserted by section #b of this ,act1 the following3 #efa;,b4 ,liability protection ,except in the case of gross negligence or willful misconduct1 any person who manufactures1 imports1 distributes1 prescribes1 dispenses1 or administers an investigational drug or device in accordance with section #efa;,a shall not be liable in any action under ,federal or ,state law for any loss1 damage1 or injury arising out of1 relating to1 or resulting from-- 7#a7 the design1 development1 clinical testing and investigation1 manufacturing1 labeling1 distribution1 sale1 purchase1 donation1 dispensing1 prescription1 administration1 or use of the drug or device2 or 7#b7 the safety or effectiveness of the drug or device4 4